Q2 2021 Holdings
Filed 2021-08-16 | 72 holdings | $224.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $91.6M | 3,335,247 | 40.8% |
| Alector Inc(ALEC) | COM | 014442107 | $88.4M | 4,242,634 | 39.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $24.8M | 321,724 | 11.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $9.6M | 3,579,377 | 4.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.6M | 200,000 | 3.4% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $580.1K | 11,284,280 | 0.3% |
| Morphic Hldg Inc | COM | 61775R105 | $226.8K | 3,951,566 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $195.0K | 7,521,024 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $169.2K | 4,906,106 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $164.2K | 4,487,776 | 0.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $127.7K | 13,711,517 | 0.1% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $96.2K | 3,318,410 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $80.9K | 2,618,036 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $77.7K | 3,724,437 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $75.0K | 464,298 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $54.7K | 3,092,218 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $52.2K | 1,967,950 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $52.0K | 2,103,950 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $35.2K | 1,411,975 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $33.7K | 9,202,702 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $31.2K | 3,421,287 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $28.9K | 1,048,976 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $26.6K | 1,035,864 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $26.1K | 1,224,175 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $25.2K | 519,416 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $25.1K | 1,260,019 | 0.0% |
| Akouos Inc | COM | 00973J101 | $24.8K | 1,975,984 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $23.8K | 6,082,200 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $21.8K | 2,358,804 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $21.0K | 2,648,163 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $20.7K | 2,426,685 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $16.8K | 754,545 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $13.2K | 931,650 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $10.6K | 200,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $9.3K | 387,357 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $9.1K | 800,000 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $9.0K | 963,333 | 0.0% |
| Allovir Inc | COM | 019818103 | $8.8K | 447,012 | 0.0% |
| Cyclerion Therapeutics Inc(CYCNUSD) | COM | 23255M105 | $6.3K | 1,606,276 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $6.0K | 100,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $5.5K | 1,000,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.0K | 500,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.7K | 522,635 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.5K | 215,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.1K | 400,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $3.6K | 366,867 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $3.2K | 38,030 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $2.9K | 831,200 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $2.8K | 143,567 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $2.6K | 105,638 | 0.0% |